Divaplon

This classification denotes a benzodiazepine with the molecular formula C17H17N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4AOV43246G, chemically known as 6-ethyl-7-methoxy-5-methylimidazo(1,2-a)pyrimidin-2-yl phenyl ketone but generally known as divaplon, which bears US NIH Compound Identifier 65822. European Medicines Agency schedules Divaplon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06338MIG. The term DIVAPLON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). DIVAPLON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule divaplon under HS 29335995 and SITC 51576. As of Q4 2014, DIVAPLON remains the US FDA Preferred Term for this commodity. Divaplon bears US NLM identifiers UMLS ID C0209249 and NCI Concept Code C65448. SMILES: O(C1NC2N(C(C1CC)C)CC(N2)C(=O)C1CCCCC1)C.